文献速递类风湿关节炎

类风湿关节炎中心力衰竭亚型的风险与时间趋势

Risk and temporal trends of heart failure subtypes in rheumatoid arthritis.
PubMed 文献 · Semin Arthritis Rheum · 2025-08-14

该回顾性匹配队列研究利用美国退伍军人健康管理局2000至2019年数据,将67,850例类风湿关节炎(RA)患者与570,933例非RA对照按年龄、性别和入组年份匹配,评估射血分数保留的心力衰竭(HFpEF)和射血分数降低的心力衰竭(HFrEF)风险及时间趋势。结果显示RA与HFpEF(aHR 1.51,95%CI 1.46-1.57)及HFpEF相关死亡(aHR 2.05,95%CI 1.76-2.39)关联最强,HFrEF风险亦升高(aHR 1.34,95%CI 1.30-1.38),且风险随时间无改善。

要点

  • RA患者HFpEF风险升高(aHR 1.51,95%CI 1.46-1.57),HFpEF相关死亡风险升高(aHR 2.05,95%CI 1.76-2.39)。
  • RA患者HFrEF风险升高(aHR 1.34,95%CI 1.30-1.38),HFrEF相关死亡风险升高(aHR 1.45,95%CI 1.29-1.63)。
  • 炎症标志物升高和血清阳性RA患者HF风险更为突出,且心力衰竭风险随时间未见改善。

核心结论

  • 在该全国性观察数据集中,RA与HFpEF及HFpEF相关死亡的关联最强。
  • 尽管RA治疗取得进展,HF亚型的风险升高未见改善。
  • 需要前瞻性研究以支持制定预防和管理策略以降低RA患者HF风险。

研究设计与样本

  • 回顾性匹配队列研究,使用美国退伍军人健康管理局2000至2019年行政和健康记录数据。
  • RA患者按年龄、性别和VHA入组年份与最多10名非RA对照匹配。
  • 共匹配67,850例RA患者(平均年龄62.5岁,87.1%男性)与570,933例非RA对照(平均年龄61.1岁,85.8%男性)。
  • 使用条件Cox回归评估HF风险,调整人口学特征、体重指数、吸烟、农村居住、医疗利用和合并症负担。
  • 按RA诊断时期(2000-2005、2006-2011、2012-2017)分层评估HF风险趋势。

主要发现

  • 随访共5,663,151人年,发生77,440例新发HF诊断。
  • 两组HF患病率随时间均增加。
  • RA与HFpEF风险升高相关(aHR 1.51,95%CI 1.46-1.57)及HFpEF相关死亡风险升高相关(aHR 2.05,95%CI 1.76-2.39)。
  • RA与HFrEF风险升高相关(aHR 1.34,95%CI 1.30-1.38)及HFrEF相关死亡风险升高相关(aHR 1.45,95%CI 1.29-1.63)。
  • 炎症标志物升高和血清阳性RA患者HF风险更为突出;所有结局的线性趋势P值均>0.05,HF风险随时间未见改善。

局限性

  • 需要前瞻性研究以支持制定预防和管理策略以降低RA患者HF风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Evaluate the risk and temporal trends of heart failure (HF) with preserved (HFpEF) and reduced ejection fraction (HFrEF) in rheumatoid arthritis (RA). METHODS: We performed a retrospective, matched cohort study using Veterans Health Administration (VHA) administrative and health record data from 2000 to 2019. Patients with RA were matched up to 10 non-RA controls on age, sex, and VHA enrollment year. Incident HF and HF-related death were queried, classifying HFpEF and HFrEF using left ventricular EF data from a validated natural language processing tool. HF risk was evaluated using conditional Cox regression, adjusting for demographics, body mass index, smoking, rurality, healthcare utilization, and comorbidity burden. Trends in HF risk were evaluated, stratifying models by RA diagnosis period (2000-2005, 2006-2011, 2012-2017). RESULTS: We matched 67,850 patients with RA (mean age 62.5, 87.1 % male) to 570,933 non-RA controls (mean age 61.1, 85.8 % male). HF prevalence increased in both groups over time. Over 5,663,151 person-years of follow-up, 77,440 incident HF diagnoses occurred. RA was associated with an increased risk of HFpEF (aHR 1.51, 95 % CI 1.46-1.57) and HFpEF-related death (2.05, 1.76-2.39), as well as HFrEF (1.34, 1.30-1.38) and HFrEF-related death (1.45, 1.29-1.63). HF risk was accentuated in RA patients with elevated inflammation and seropositive RA. No improvements in HF risk were observed over time (linear p-for-trend >0.05 for all outcomes). CONCLUSION: RA was most strongly associated with HFpEF and HFpEF-related death in this national-level, observational dataset. Heightened risks of HF subtypes have not improved despite advances in RA treatment. Prospective research is needed to support the development ofprevention and management strategies to mitigate HF risk in RA.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Johnson TM, Yang Y, Roul P, et al. Risk and temporal trends of heart failure subtypes in rheumatoid arthritis. Semin Arthritis Rheum. 2025. PMID: 40845733. doi:10.1016/j.semarthrit.2025.152816

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。